 |
인쇄하기
취소
|
MSD vaccine business went far ahead to GSK in Korea.
A sharp business competition between GSK and MSD seems to surface on the market
with the cervical cancer and rotavirus vaccines.
MSD Korea snatched the market initiative with Rotateq, a rotavirus vaccine, in more than 70 countries as well as with Gardasil, a cervical cancer vaccine far ahead to the equivalent vaccines such as Rotarix and Cervarix that are currently on research by GSK and e...
with the cervical cancer and rotavirus vaccines.
MSD Korea snatched the market initiative with Rotateq, a rotavirus vaccine, in more than 70 countries as well as with Gardasil, a cervical cancer vaccine far ahead to the equivalent vaccines such as Rotarix and Cervarix that are currently on research by GSK and e...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.